MedTrace Logo

Spot Depression Study

NCT02804867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-02-23

No results posted yet for this study

Summary

This study aims to identify signs of depression and bipolar disorder by measuring changes of certain molecules (biomarkers) that can be detected in dried blood spots. Our goal is to use these biomarkers to develop a diagnostic test to enable early treatment, which can lead to better patient outcomes.

Conditions

Interventions

PROCEDURE

Online questionnaire and self-administered blood spot

Sponsors & Collaborators

Principal Investigators

  • Sabine Bahn, MD/PhD · Principal Investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02804867 on ClinicalTrials.gov